Starting the week of September 22, Ontario residents aged 60 to 74 who meet certain high-risk criteria or live in specific ...
The ministry also highlighted that, in 2025 alone, reimbursement has already been extended to 151 new therapies, the highest figure ever recorded. As the Polish Deputy Health Minister, Katarzyna ...
Deadly for the Elderly and Infants'Respiratory Syncytial Virus (RSV) Infection' Experts are urging that vaccination should be ...
Toronto — Ontario is rolling out an expanded fall immunization campaign aimed at protecting residents from a seasonal surge ...
GSK faces U.S. vaccine sales declines as Shingrix and Arexvy stumble. Penmenvy approval and pipeline efforts may aid long-term growth.
HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published in JAMA Network Open.
iPaediatric Emergency Department and General Pediatrics Department, Louis Mourier University Hospital, Assistance Publique-Hôpitaux de Paris, Paris Cité Université, Colombes, France jPaediatric ...
Two new real-world studies estimate the effectiveness of a single dose of a respiratory syncytial virus (RSV) vaccine against ...
Infants under eight months and adults 75 years and older will soon have access to free protection ...
Nova Scotia is spending $6.9 million to launch a new program to vaccinate or protect infants and some seniors against ...
Mississauga, Ontario Wednesday, September 10, 2025, 14:00 Hrs [IST] ...
13d
GSK's RSV Vaccine Arexvy Included in Publicly Funded Prevention Programs for Older Adults in Canada
GSK announced today that Arexvy (respiratory syncytial virus vaccine - recombinant, AS01E adjuvanted) will be offered through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback